Cited by 32Alzheimer's disease research and treatmentsProtein Kinase Regulation and GTPase SignalingNeuroscience and Neuropharmacology Research

Rac1 changes the substrate specificity of γ-secretase between amyloid precursor protein and Notch1

Boo, Jung Hyun, Sohn, Ji Hoon, Kim, Ji Eun, Song, Hyundong, Mook-Jung, Inhee·2008·Biochemical and Biophysical Research Communications

Abstract

Beta amyloid peptide is generated from amyloid precursor protein (APP) by proteolytic cleavage of beta- and gamma-secretases, and plays a critical role in the pathogenesis of Alzheimer's disease. Since gamma-secretase cleaves several proteins including APP and Notch in a number of cell types, it is important to understand the conditions determining gamma-secretase substrate specificity. In the present study, inhibition of Rac1 attenuated gamma-secretase activity for APP, resulting in decreased production of the APP intracellular domain but accumulated C-terminal fragments (APP-CTF). In contrast, Rac1 inhibitor, NSC23766 increased production of the Notch1 intracellular domain but slightly decreased the ectodomain-shed form of Notch1 (NotchDeltaE). To elucidate the mechanism underlying these observations, we performed co-immunoprecipitation experiments to analyze the interaction between Rac1 and presenilin1 (PS1), a component of the gamma-secretase complex. Inhibition of Rac1 enhanced its interaction with PS1. Under the same condition, PS1 interacted more strongly with NotchDeltaE than with APP-CTF. Our results suggested that PS1 determines the preferred substrate for gamma-secretase between APP and Notch1, depending on the activation status of Rac1.

Integrity signals

Registry

Crossref · 10.1016/j.bbrc.2008.05.153

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In mouse primary hippocampal neurons, RAC1 inhibition with compound NSC23766 leads to attenuated γ-secretase activity, reduction in cellular APP, and subsequent β-amyloid plaque formation.

    “This can be inferred from mouse primary hippocampal neuronal experiments, where RAC1 inhibition with compound NSC23766 leads to attenuated γ-secretase activity, resulting in a reduction in cellular amyloid precursor protein (APP) and subsequent β-amyloid plaque formation, a hallmark of Alzheimer’s disease (AD) (29).”
  • The activation of RAC1 in a cell line or primary cultured cortical neurons increased Aβ levels and tau hyperphosphorylation.

    “The activation of RAC1 in a cell line or primary cultured cortical neurons increased Aβ levels and tau hyperphosphorylation.”
  • Inhibition of RAC1 attenuated γ-secretase activity for APP.

    “Inhibition of RAC1 attenuated γ-secretase activity for APP151.”

The citation lists haven’t been fetched yet

References 32 · Cited by 32

Authors
Boo, J. H., Sohn, J. H., Kim, J. E., Song, H., & Mook-Jung, I.
Affiliations
Seoul National University (KR)
Venue
Biochemical and Biophysical Research Communications
Publisher
Elsevier BV
Published
2008-08
Volume
372
Issue
4
Pages
913-917
ISSN
0006-291X (ISSN-L)
OpenAlex
W2007696560
Cited by
32
References
32
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 2 · 2021: 1 · 2020: 1 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 2 · 2014: 4 · 2013: 5
FWCI
1.58
Type
journal article
Language
en
Open access
closed
Locations
  • Biochemical and Biophysical Research Communications (publishedVersion)
  • PubMed (publishedVersion)
  • Seoul National University Open Repository (Seoul National University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
Rac1, gamma-secretase, substrate specificity, amyloid precursor protein, Notch1, presenilin 1, APP intracellular domain, APP C-terminal fragments, amyloid-beta, Alzheimer's disease
MeSH terms
Alzheimer Disease, Aminoquinolines, Animals, Cell Line, Chlorocebus aethiops, Enzyme Activation, Humans, Pyrimidines, Substrate Specificity, Drug Design, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Sequence Deletion, Protein Structure, Tertiary, COS Cells, rac1 GTP-Binding Protein, Receptor, Notch1, Presenilin-1, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review